Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Reichenspurner

Showing results (401-410 of 555) with videos related to

Pageof 56
Sort By:
International Journal of Cardiology|February 11, 2021
Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation networkNina Fluschnik, Bastiaan Geelhoed, Peter Moritz Becher, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2021
Heyde syndrome: prevalence and outcomes in patients undergoing transcatheter aortic valve implantationLara Waldschmidt, Andreas Drolz, Paula Heimburg, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 1, 2019
Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysisAndreas Schaefer, Niklas Schofer, Alina Goßling, et al.
Clinical Transplantation|June 9, 2025
Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery DiseaseLukas Köster, Jessica Weimann, Alexander Bernhard, et al.
Tissue Engineering. Part A|October 26, 2013
In vitro perfusion of engineered heart tissue through endothelialized channelsIngra Vollert, Moritz Seiffert, Johanna Bachmair, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2013
Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experiencePatrick Diemert, Philipp Lange, Martin Greif, et al.
Stem Cells Translational Medicine|May 8, 2015
Immunobiology of fibrin-based engineered heart tissueLenard Conradi, Stephanie Schmidt, Evgenios Neofytou, et al.
Journal of the American College of Cardiology|November 15, 2011
Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgeryVolker Rudolph, Malgorzata Knap, Olaf Franzen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2017
The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections†Alexander M Bernhardt, Mustafa A Pamirsad, Chantal Brand, et al.
Journal of the American Heart Association|January 18, 2021
Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long-Term OutcomeLeon Dinshaw, Paula Münkler, Benjamin Schäffer, et al.
Pageof 56

Showing results (401-410 of 555) with videos related to

Sort By:
Pageof 56
International Journal of Cardiology|February 11, 2021
Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation networkNina Fluschnik, Bastiaan Geelhoed, Peter Moritz Becher, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2021
Heyde syndrome: prevalence and outcomes in patients undergoing transcatheter aortic valve implantationLara Waldschmidt, Andreas Drolz, Paula Heimburg, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 1, 2019
Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysisAndreas Schaefer, Niklas Schofer, Alina Goßling, et al.
Clinical Transplantation|June 9, 2025
Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery DiseaseLukas Köster, Jessica Weimann, Alexander Bernhard, et al.
Tissue Engineering. Part A|October 26, 2013
In vitro perfusion of engineered heart tissue through endothelialized channelsIngra Vollert, Moritz Seiffert, Johanna Bachmair, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2013
Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experiencePatrick Diemert, Philipp Lange, Martin Greif, et al.
Stem Cells Translational Medicine|May 8, 2015
Immunobiology of fibrin-based engineered heart tissueLenard Conradi, Stephanie Schmidt, Evgenios Neofytou, et al.
Journal of the American College of Cardiology|November 15, 2011
Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgeryVolker Rudolph, Malgorzata Knap, Olaf Franzen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2017
The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections†Alexander M Bernhardt, Mustafa A Pamirsad, Chantal Brand, et al.
Journal of the American Heart Association|January 18, 2021
Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long-Term OutcomeLeon Dinshaw, Paula Münkler, Benjamin Schäffer, et al.
Pageof 56